Agency Information Collection Request; 60-Day Public Comment Request, 71341-71342 [2022-25343]
Download as PDF
<![CDATA[
71341
Federal Register / Vol. 87, No. 224 / Tuesday, November 22, 2022 / Notices
agenda and instructions to access the
broadcast of the meeting will be posted.
Should you require reasonable
accommodation, please telephone the
CDC Office of Equal Employment
Opportunity at (770) 488–3210 as soon
as possible.
SUPPLEMENTARY INFORMATION:
Purpose: As outlined in its Charter,
the National Committee on Vital and
Health Statistics assists and advises the
Secretary of HHS on health data, data
standards, statistics, privacy, national
health information policy, and the
Department’s strategy to best address
those issues. At this meeting, the
Committee will receive updates from
HHS officials, hold discussions on
current health data policy topics, and
discuss its work plan for the upcoming
period. The Subcommittee on Privacy,
Confidentiality and Security (PCS) will
present a recent environmental scan it
commissioned entitled, ‘‘Ongoing and
Emerging Issues in Privacy and Security
in a Post-COVID–19 Era,’’ and discuss
with fellow members potential
opportunities where the Committee’s
advice to HHS may be useful. The PCS
Subcommittee also will review with the
full Committee possible development of
recommendations stemming from
briefings held during the Committee’s
July 21, 2022, meeting specific to data
access and privacy for Tribal
Epidemiology Centers.
The Subcommittee on Standards will
brief the Committee on preparations for
its January 18–19, 2023, hearing focused
on requests for new and updated
transaction standards and operating
rules. See the notice and request for
comment regarding this meeting
published at 87 Federal Register 65782
on November 1, 2022, and available at
this link: https://www.govinfo.gov/
content/pkg/FR-2022-11-01/pdf/202223678.pdf. The briefing will include an
update on collaborations with the
Workgroup on Electronic Data
Interchange (WEDI)—also an advisor to
the Secretary of Health and Human
Services (HHS)—to inform deliberations
as the Committee considers drafting
recommendations to HHS on proposed
new and updated standards and
operating rules. The Subcommittee on
Standards also will update the full
Committee on follow up activities to
previous recommendations on the
transition to the 11th Revision of the
International Classification of Diseases
(ICD–11) and discuss plans for the year
ahead. Last, the Committee will identify
areas of focus for its 2023 Report to
Congress.
The Committee will reserve time for
public comment toward the end of the
agenda on both days. Meeting times and
topics are subject to change. Please refer
to the agenda posted on the NCVHS
website for updates: https://
ncvhs.hhs.gov/meetings/full-committeemeeting-12/.
Sharon Arnold,
Associate Deputy Assistant Secretary, Science
and Data Policy, Office of the Assistant
Secretary for Planning and Evaluation.
[FR Doc. 2022–25334 Filed 11–21–22; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–New]
Agency Information Collection
Request; 60-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before January 23, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990-New-60D
SUMMARY:
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, or call (202)
264–0041 the Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Confidentiality
of Substance Use Disorder Patient
Records—42 CFR part 2 (formerly titled
Confidentiality of Alcohol and Drug
Abuse Patient Records—42 CFR part 2).
Type of Collection: Extension.
OMB No.: 0930–0092.
Abstract: The Substance Abuse and
Mental Health Services Administration
(SAMHSA) (through the Office for Civil
Rights (OCR) requests approval to
extend this existing, approved
collection without changing any
collecting requirements. OCR also
expects to obtain public comment
through a Notice of Proposed
Rulemaking (NPRM) proposing
modifications to 42 CFR part 2 that will
affect the hourly burdens associated
with the regulations. When the NPRM is
published, we expect to receive robust
public comment on existing burdens
associated with compliance with the
part 2 regulation and on changes in
burden that could result from the
modifications proposed in the NPRM.
OCR will update this ICR to reflect the
input we receive on this notice and
through the rulemaking process.
Likely Respondents: Part 2 programs,
qualified service organizations, patients
with substance use disorders, and
professional and trade associations of
SUD treatment providers.
ANNUALIZED BURDEN HOUR TABLE
Annual number
respondents
(SUD programs)
khammond on DSKJM1Z7X2PROD with NOTICES
42 CFR
Responses
per
respondent
Total
responses
(number of Tx
admissions)
Hours per
response
Total hour
burden
§ 2.22 ................................................................................
§§ 2.31, 2.52, and 2.53 ....................................................
§ 2.36 ................................................................................
§ 2.51 ................................................................................
13,585
13,585
13,585
13,585
122.1
18.31
195.8
2
1,658,729
248,741
2,659,943
27,170
0.20
0.62
0.033
0.167
331,746
155,463
87,778
4,537
Total ..........................................................................
13,585
........................
4,594,583
........................
579,524
VerDate Sep<11>2014
17:48 Nov 21, 2022
Jkt 259001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\22NON1.SGM
22NON1
71342
Federal Register / Vol. 87, No. 224 / Tuesday, November 22, 2022 / Notices
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–25343 Filed 11–21–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings of the Advisory
Committee to the Director, National
Institutes of Health.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend as well
as those who need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting. The
meeting sessions will be videocast and
can be accessed from the NIH
Videocasting website (https://
videocast.nih.gov/).
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 8, 2022.
Time: 9:00 a.m. to 5:15 p.m.
Agenda: Performing the Duties of the NIH
Director’s Report; Updates on ARPA–H and
COVID–19; Perspectives on the Current
Cooperation with NIH and Priorities for the
Future; Proposed Changes to Peer Review
Criteria; ACD Working Group Updates; Other
Business of the Committee.
Date: December 9, 2022.
Time: 9:00 a.m. to 3:15 p.m.
Agenda: HeLA Genome Data Access
Requests; NIH RECOVER Initiative; NIH
Efforts in Support of Open Data; Diversity,
Equity, Inclusion and Accessibility (DEIA)
Strategic Plan; ACD Working Group Updates;
Update on UNITE; Other Business of the
Committee.
Place: National Institutes of Health,
Building 1, Wilson Hall, One Center Drive,
Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–2433, shawcy@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
VerDate Sep<11>2014
17:48 Nov 21, 2022
Jkt 259001
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Additional Health and Safety Guidance:
Before attending a meeting at an NIH facility,
it is important that visitors review the NIH
COVID–19 Safety Plan at https://ors.od.nih.
gov/sr/dohs/safety/NIH-covid-19-safety-plan/
Pages/default.aspx for information about
requirements and procedures for entering
NIH facilities, especially when COVID–19
community levels are medium or high. In
addition, the Safer Federal Workforce
website has FAQs for visitors at https://
www.saferfederalworkforce.gov/faq/visitors/.
Please note that if an individual has a
COVID–19 diagnosis within 10 days of the
meeting, that person must attend virtually.
(For more information please read NIH’s
Requirements for Persons after Exposure at
https://ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVID-assessmenttesting/Pages/persons-after-exposure.aspx
and What Happens When Someone Tests
Positive at https://ors.od.nih.gov/sr/dohs/
safety/NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.aspx.)
Anyone from the public can attend the open
portion of the meeting virtually via the NIH
Videocasting website (https://
videocast.nih.gov). Please continue checking
these websites, in addition to the committee
website listed below, for the most up to date
guidance as the meeting date approaches.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 16, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Acquired Immunodeficiency
Syndrome Research Study Section Acquired
Immunodeficiency Syndrome Research
Study Section (AIDS).
Date: December 15, 2022.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room
3G21,Rockville, MD 20892 (Virtual Meeting).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G21, Bethesda, MD
20852, (240) 669–5035, robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 16, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–25396 Filed 11–21–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2022–25389 Filed 11–21–22; 8:45 am]
Center for Scientific Review; Notice of
Closed Meeting
BILLING CODE 4140–01–P
PO 00000
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 87, Number 224 (Tuesday, November 22, 2022)]
[Notices]
[Pages 71341-71342]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25343]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier: OS-0990-New]
Agency Information Collection Request; 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before January 23,
2023.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 264-0041.
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-New-60D and
project title for reference, to Sherrette A. Funn, email:
[email protected], or call (202) 264-0041 the Reports Clearance
Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Confidentiality of Substance Use Disorder
Patient Records--42 CFR part 2 (formerly titled Confidentiality of
Alcohol and Drug Abuse Patient Records--42 CFR part 2).
Type of Collection: Extension.
OMB No.: 0930-0092.
Abstract: The Substance Abuse and Mental Health Services
Administration (SAMHSA) (through the Office for Civil Rights (OCR)
requests approval to extend this existing, approved collection without
changing any collecting requirements. OCR also expects to obtain public
comment through a Notice of Proposed Rulemaking (NPRM) proposing
modifications to 42 CFR part 2 that will affect the hourly burdens
associated with the regulations. When the NPRM is published, we expect
to receive robust public comment on existing burdens associated with
compliance with the part 2 regulation and on changes in burden that
could result from the modifications proposed in the NPRM. OCR will
update this ICR to reflect the input we receive on this notice and
through the rulemaking process.
Likely Respondents: Part 2 programs, qualified service
organizations, patients with substance use disorders, and professional
and trade associations of SUD treatment providers.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Total
Annual number Responses per responses Hours per Total hour
42 CFR respondents respondent (number of Tx response burden
(SUD programs) admissions)
----------------------------------------------------------------------------------------------------------------
Sec. 2.22................... 13,585 122.1 1,658,729 0.20 331,746
Sec. Sec. 2.31, 2.52, and 13,585 18.31 248,741 0.62 155,463
2.53.........................
Sec. 2.36................... 13,585 195.8 2,659,943 0.033 87,778
Sec. 2.51................... 13,585 2 27,170 0.167 4,537
---------------------------------------------------------------------------------
Total..................... 13,585 .............. 4,594,583 .............. 579,524
----------------------------------------------------------------------------------------------------------------
[[Page 71342]]
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-25343 Filed 11-21-22; 8:45 am]
BILLING CODE 4162-20-P
